Literature DB >> 15217317

Leprosy patients with lepromatous disease have an up-regulated IL-8 response that is unlinked to TNF-alpha responses.

Z Hasan1, A Mahmood, S Zafar, A A Khan, R Hussain.   

Abstract

Tumor necrosis factor (TNF-alpha) in conjunction with interferon-gamma (IFN-gamma) plays an important role in lymphocyte recruitment and granuloma formation in mycobacterial diseases. Lepromatous leprosy infections are typically associated with low to absent T cell responses and the absence of INF-gamma secretion. Chemokines such as IL-8, MCP-1, and MIP-1beta, have also been shown to recruit neutrophils and lymphocytes to the site of mycobacterial infections. We have studied IL-8 expression in relation to TNF-alpha and TGF-beta in monocytes from lepromatous patients (LL) as compared with healthy endemic controls. In endemic controls, no spontaneous expression of IL-8, TNF-alpha, and TGF-beta was observed, but BCG and M. leprae induced activation of all three cytokines. Lepromatous leprosy monocytes spontaneously expressed high levels of IL-8 and TGF-beta but negligible levels of TNF-alpha. A further increase in IL-8 secretion or gene expression by BCG or M. leprae was not significant. BCG, but not M. leprae, was able to stimulate TNF-alpha activation in lepromatous leprosy subjects. TGF-beta responses in LL were parallel to those of IL-8. This suggests a vigorous and active ongoing IL-8 response in lepromatous disease that is independent of TNF-alpha activation. Therefore, in the absence of IFN-gamma and TNF-alpha activation, IL-8 may assume a pivotal role in cell recruitment in leprosy patients with disseminated mycobacterial infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15217317     DOI: 10.1489/1544-581X(2004)072<0035:LPWLDH>2.0.CO;2

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  6 in total

1.  Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis.

Authors:  Zahra Hasan; Irfan Zaidi; Bushra Jamil; M Aslam Khan; Akbar Kanji; Rabia Hussain
Journal:  BMC Immunol       Date:  2005-07-07       Impact factor: 3.615

2.  M. leprae inhibits apoptosis in THP-1 cells by downregulation of Bad and Bak and upregulation of Mcl-1 gene expression.

Authors:  Zahra Hasan; Mussarat Ashraf; Ali Tayyebi; Rabia Hussain
Journal:  BMC Microbiol       Date:  2006-09-18       Impact factor: 3.605

3.  PGL I expression in live bacteria allows activation of a CD206/PPARγ cross-talk that may contribute to successful Mycobacterium leprae colonization of peripheral nerves.

Authors:  Chyntia Carolina Díaz Acosta; André Alves Dias; Thabatta Leal Silveira Andrezo Rosa; Leonardo Ribeiro Batista-Silva; Patricia Sammarco Rosa; Thiago Gomes Toledo-Pinto; Fabrício da Mota Ramalho Costa; Flávio Alves Lara; Luciana Silva Rodrigues; Katherine Antunes Mattos; Euzenir Nunes Sarno; Patrícia Torres Bozza; Christophe Guilhot; Márcia de Berrêdo-Pinho; Maria Cristina Vidal Pessolani
Journal:  PLoS Pathog       Date:  2018-07-06       Impact factor: 6.823

4.  Serum Interleukin 6 Level and Nutrition Status as Potential Predictors of Clinical Leprosy Development Among Household Contacts in Endemic Areas.

Authors:  Salma Oktaria; Fatih Anfasa; Sri Linuwih Menaldi; Kusmarinah Bramono; Tamar E C Nijsten; Hok Bing Thio
Journal:  Open Forum Infect Dis       Date:  2022-02-02       Impact factor: 3.835

5.  Expression of M. tuberculosis-induced suppressor of cytokine signaling (SOCS) 1, SOCS3, FoxP3 and secretion of IL-6 associates with differing clinical severity of tuberculosis.

Authors:  Kiran I Masood; Martin E Rottenberg; Naseem Salahuddin; Muhammad Irfan; Nisar Rao; Berit Carow; Muniba Islam; Rabia Hussain; Zahra Hasan
Journal:  BMC Infect Dis       Date:  2013-01-15       Impact factor: 3.090

6.  Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan.

Authors:  Mahnaz Tanveer; Zahra Hasan; Amna R Siddiqui; Asho Ali; Akbar Kanji; Solomon Ghebremicheal; Rumina Hasan
Journal:  BMC Infect Dis       Date:  2008-12-24       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.